MicroPort NeuroTech Valuation
Is 2172 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Por debajo del valor justo
Muy por debajo del valor justo
Price-To-Earnings vs. similares
Price-To-Earnings vs. Industria
PM vs. Ratio Justo
Pronóstico de los analistas
Share Price vs Fair Value
What is the Fair Price of 2172 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Por debajo del valor justo: 2172 (HK$8.2) cotiza por debajo de nuestra estimación de valor razonable (HK$16.11)
Muy por debajo del valor justo: 2172 cotiza por debajo de su valor justo en más de un 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2172?
Other financial metrics that can be useful for relative valuation.
| What is 2172's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CN¥4.41b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 5.1x |
| Enterprise Value/EBITDA | 13.7x |
| PEG Ratio | 0.9x |
Price to Earnings Ratio vs Peers
How does 2172's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 52.8x | ||
1789 AK Medical Holdings | 27.5x | 25.8% | HK$5.4b |
1302 LifeTech Scientific | 26.5x | 20.5% | HK$7.5b |
3600 Modern Dental Group | 9.8x | 12.2% | HK$4.0b |
6669 Acotec Scientific Holdings | 147.3x | 48.0% | HK$2.3b |
2172 MicroPort NeuroTech | 30.3x | 32.6% | HK$4.8b |
Price-To-Earnings vs. similares: 2172 es un buen valor basado en su Ratio Price-To-Earnings (31x) comparado con la media de sus homólogos (55.7x).
Price to Earnings Ratio vs Industry
How does 2172's PE Ratio compare vs other companies in the HK Medical Equipment Industry?
Price-To-Earnings vs. Industria: 2172 es caro en función de su Ratio Price-To-Earnings (39.4x) en comparación con la media del sector Hong Kong Medical Equipment (12.3x).
Price to Earnings Ratio vs Fair Ratio
What is 2172's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 30.3x |
| Fair PE Ratio | 18.4x |
PM vs. Ratio Justo: 2172 es caro en función de su Ratio Price-To-Earnings (39.4x) comparado con el Ratio Price-To-Earnings estimado (20x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | HK$8.20 | HK$15.14 +84.6% | 17.4% | HK$17.77 | HK$12.50 | n/a | 2 |
| Mar ’25 | HK$9.82 | HK$20.03 +104.0% | 13.5% | HK$23.85 | HK$17.96 | n/a | 3 |
| Feb ’25 | HK$8.89 | HK$20.03 +125.3% | 13.5% | HK$23.85 | HK$17.96 | n/a | 3 |
| Jan ’25 | HK$12.24 | HK$19.78 +61.6% | 14.6% | HK$23.87 | HK$17.59 | n/a | 3 |
| Dec ’24 | HK$11.94 | HK$19.78 +65.7% | 14.6% | HK$23.87 | HK$17.59 | n/a | 3 |
| Nov ’24 | HK$12.70 | HK$20.82 +63.9% | 14.3% | HK$23.80 | HK$17.84 | n/a | 2 |
| Oct ’24 | HK$12.18 | HK$20.82 +70.9% | 14.3% | HK$23.80 | HK$17.84 | n/a | 2 |
| Sep ’24 | HK$12.10 | HK$21.99 +81.7% | 23.4% | HK$29.26 | HK$18.01 | n/a | 3 |
| Aug ’24 | HK$13.30 | HK$24.16 +81.7% | 22.0% | HK$29.48 | HK$18.84 | n/a | 2 |
Pronóstico de los analistas: El precio objetivo es más de 20% superior al precio actual de la acción, pero no hay suficientes analistas que cubran el valor para determinar confianza estadística en el acuerdo.